Способ профилактики рвоты после лапароскопических холецистэктомий. Заболотских И.Б - 16 стр.

45. Pavlin D.J., Rapp S.E., Polissar N.L, Malmgren J.A., Koerschgen M., Keyes H.
    Factors affecting discharge time in adult outpatients.// Anesth. Analg. 1998 Oct;
    87(4): 816-26
46. Riley T.J., McKenzie R., Trantisira B.R., Hamilton D.L. Droperidol-ondansetron
    combination versus droperidol alone for postoperative control of emesis after total
    abdominal hysterectomy.// J. Clin. Anesth. 1998 Feb; 10(1): 6-12
47. Rothenberg D. M., McCarthy R.J., Peng C.C., Normoyle D.A. Nausea and vomit-
    ing after dexamethasone versus droperidol following outpatient laparoscopy with
    a propofol-based general anesthetic.// Acta Anaesthesiol. Scand. 1998 Jul; 42(6):
    637-42
48. Schlager A. Akupunktur in der Prophylaxe von postoperativer Ubelkeit und Er-
    brechen.// Wien. Med. Wochenschr. 1998; 148(19): 454-6
49. Scholz J., Hennes H.J., Steinfath M., Farber L., Schweiger C., Dick W., Schulte-
    am-Esch J. Tropisetron or ondansetron compared with placebo for prevention of
    postoperative nausea and vomiting.// Eur. J. Anaesthesiol. 1998 Nov; 15(6): 676-
    85
50. Sinha P.K., Tripathi M., Ambesh S.P. Efficacy of ondansetron in prophylaxis of
    postoperative nausea and vomiting in patients following infratentorial surgery: a


                                                 u
                                               .r
    placebo-controlled prospective double-blind study.// J. Neurosurg. Anesthesiol.
                                           od
    1999 Jan; 11(1): 6-10
51. Song D., Whitten C.W., White P.F., Yu S.Y., Zarate E. Antiemetic activity of
                                       ar


    propofol after sevoflurane and desflurane anesthesia for outpatient laparoscopic
                                    .n



    cholecystectomy// Anesthesiology. 1998 Oct; 89(4): 838-43
                                th




52. Soyannwo O.A., Ajuwon A.J., Amanor-Boadu S.D., Ajao O.G. Post operative
                            es




    nausea and vomiting in Nigerians.// East. Afr. Med. J. 1998 Apr; 75(4): 243-5
53. Tang J., D'Angelo R., White P.F., Scuderi P.E. The efficacy of RS-25259, a long-
                          n




    acting selective 5-HT3 receptor antagonist, for preventing postoperative nausea
                      ba




    and vomiting after hysterectomy procedures.// Anesth. Analg. 1998 Aug; 87(2):
                  ku




    462-7
54. Tang J., Wang B., White PF., Watcha M.F., Qi J., Wender R.H. The effect of tim-
    ing of ondansetron administration on its efficacy, cost-effectiveness, and cost-
    benefit as a prophylactic antiemetic in the ambulatory setting.// Anesth. Analg.
    1998 Feb; 86(2): 274-82
55. Thomson D. More attention should be paid to PONV and patient satisfaction in
    the postoperative period.// Eur. J. Anaesthesiol. 1998 Nov; 15(6): 752
56. Tramer M., Moore A., McQuay H. Meta-analytic comparison of prophylactic an-
    tiemetic efficacy for postoperative nausea and vomiting: propofol anaesthesia vs
    omitting nitrous oxide vs total i.v. anaesthesia with propofol.// Br. J. Anaesth.
    1997 Mar; 78(3): 256-9
57. Tramer M., Moore A., McQuay H. Propofol anaesthesia and postoperative nausea
    and vomiting: quantitative systematic review of randomized controlled studies.//
    Br. J. Anaesth. 1997 Mar; 78(3): 247-55
58. Tramer M.R., Moore R.A., Reynolds D.J., McQuay H.J. A quantitative systematic
    review of ondansetron in treatment of established postoperative nausea and vomit-
    ing.// BMJ. 1997 Apr 12; 314(7087): 1088-92

                                          16